Covid-19 associated aspergillosis

ABSTRACT

Invasive pulmonary aspergillosis (IPA) may complicate severe COVID-19 patients. The incidence, although is not well confirmed, varies (20-35%) and the already recognized host factors for IPA in immunosuppressed patients are not identified in non-immunocom-promised patients with COVID-19 associated pulmonary aspergil-losis (CAPA). Additionally, clinical characteristics and radiological findings are not specific. Given the probable high burden of the co-infection, a screening diagnostic work-up, including serum and BAL galactomannan measurement, fungal cultures of upper and lower respiratory tract samples are considered mandatory in all mechanically ventilated patients with COVID-19. Pneumon 2020, 33(2)1-4. © 2020, Technogramma. All rights reserved.